Skip to main content
. 2023 Jul 22;15:118. doi: 10.1186/s13148-023-01535-4

Fig. 5.

Fig. 5

Fig. 5

Circulating NPTX2 methylation status for monitoring response to therapy and disease progression in mPDAC patients. The left Y-axis represents the percentage of NPTX2 methylation in plasma. Right inner Y-axis represents the RAS mutant allele fraction (MAF, %) and right outer Y-axis represents CA19-9 (U/mL). The different treatments are indicated with different colors, and the shaded intervals indicate the lead time window of NPTX2 in relation to disease progression. Bars indicate Poisson's error (95% CI)